dihexa pnb-0408 c-met hgfr activator Small molecule activation of the neurotrophin hepatocyte growth factor to treat Alzheimer disease Dihexa (PNB -0408) MET – an ideal target
MET an ideal target for antibody drug conjugate therapy, plus nivolumab Cancer Biology dihexa peptide cognitive enhancement neurodegeneration Growth Factors and Their Application in the Therapy of Hereditary Neurodegenerative Diseases Dihexa (PNB 0408) c Met HGFR Activator dihexa n hexanoyl tyr ile 6 aminohexanamide Dihexa 1401708 83 5 Dihexa;PNB 0408; N hexanoic Try Ile (6) amino hexanoic amide dihexa chemical properties solubility stability dihexa water solubility mg ml Elzovantinib (TPX 0022) c Met inhibitor
Pay in 4 interest-free payments of $6.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27



